Personalis (NASDAQ: PSNL) net income
Personalis reported a net loss of $81.3m for fiscal 2025; in fiscal 2024 it reported a net loss of $81.3m. Earnings per share were −$0.91.
Personalis's best year of the last 8 was fiscal 2018. It reported a loss in 8 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$81.3m | — | −116.7% | −$0.91 |
| 2024 | −$81.3m | — | −96.1% | −$1.37 |
| 2023 | −$108.3m | — | −147.4% | −$2.25 |
| 2022 | −$113.3m | — | −174.2% | −$2.48 |
| 2021 | −$65.2m | — | −76.3% | −$1.49 |
| 2020 | −$41.3m | — | −52.5% | −$1.20 |
| 2019 | −$25.1m | — | −38.5% | — |
| 2018 | −$19.9m | — | −52.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Personalis net income compared with its sector
By net income for its latest fiscal year, Personalis ranks 318th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Personalis, −116.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 316th | Arvinas | −$80.8m | −30.8% |
| 317th | Zymeworks | −$81.1m | −76.6% |
| 318th | Personalis | −$81.3m | −116.7% |
| 319th | Enanta Pharmaceuticals | −$81.9m | −125.4% |
| 320th | LENZ Therapeutics | −$82.1m | −430.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Personalis
- How much did Personalis earn in fiscal 2025?
- Personalis reported a net loss of $81.3m for fiscal 2025. In fiscal 2024 it reported a net loss of $81.3m.
- What are the earnings per share of Personalis?
- They were −$0.91 in fiscal 2025, compared with −$1.37 in fiscal 2024.
- Where does Personalis rank in its sector by net income?
- It ranks 318th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Personalis come from?
- From the annual report (Form 10-K) that Personalis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Personalis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Personalis: the Personalis page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.